Literature DB >> 32912252

Comment on "The diagnostic value of D-dimer with simplified Geneva score (SGS) pre-test in the diagnosis of pulmonary embolism (PE)".

Siamak Sabour1,2.   

Abstract

Any decision in clinical practice needs to evaluate both reliability (precision) and validity (accuracy) of a diagnostic test. Without knowledge about the reliability, any judgment would be wrong. In diagnostic accuracy research, it is essential to evaluate the diagnostic added value of a test, since a diagnostic accuracy of a single test might be excellent, however for clinical purposes it can be worthless. Like evaluating discrimination, it would be possible to estimate the diagnostic added value by applying ROC of diagnostic model with and without test results in the model.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32912252      PMCID: PMC7488250          DOI: 10.1186/s13019-020-01301-0

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


To the Editor. I read the paper from Zhihui Fu et al. published in J Cardiothorac Surg [1]. The aim of the study was to assess the diagnostic value of D-dimer with simplified Geneva score (SGS) pre-test in the diagnosis of pulmonary embolism (PE). In a retrospective analysis, 1035 patients with suspected PE were recruited. All enrolled patients were grouped according to the computed tomographic pulmonary angiogram (CTPA) results: PE patients and non-PE patients. Then, receiver operating characteristic (ROC) curve were constructed to determine the optimal D-dimer cutoff point value which is based on Yonden’s index (YI). Although I appreciate this significant study, I would like to raise some methodological issues that can affect the interpretation of results. First, any decision in clinical practice needs to evaluate both reliability (precision) and validity (accuracy) of CTPA. Without knowledge about the reliability, any judgment would be wrong [2-6]. Second, in diagnostic accuracy research, it is essential to evaluate the diagnostic added value of CTPA, since a diagnostic accuracy of a single test might be excellent, however for clinical purposes it can be worthless. Like evaluating discrimination, it would be possible to estimate the diagnostic added value by applying ROC of diagnostic model with and without CTPA [2, 7, 8]. Hence, we suggest the authors to estimate both diagnostic added value and reliability of the CTPA by an appropriate method.
  7 in total

1.  Reproducibility of dynamic Scheimpflug-based pneumotonometer and its correlation with a dynamic bidirectional pneumotonometry device: methodological issues.

Authors:  Siamak Sabour
Journal:  Cornea       Date:  2015-05       Impact factor: 2.651

2.  A Common Mistake in Assessing the Diagnostic Value of a Test: Failure to Account for Statistical and Methodologic Issues.

Authors:  Siamak Sabour
Journal:  J Nucl Med       Date:  2017-01-12       Impact factor: 10.057

3.  Accuracy, validity, and reliability of the infrared optical head tracker (IOHT).

Authors:  Siamak Sabour; Fariba Ghassemi
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-13       Impact factor: 4.799

4.  Reproducibility of semi-automatic coronary plaque quantification in coronary CT angiography with sub-mSv radiation dose; common mistakes.

Authors:  Siamak Sabour
Journal:  J Cardiovasc Comput Tomogr       Date:  2016-07-09

5.  Reproducibility of diagnostic criteria associated with atypical breast cytology: A methodological issue.

Authors:  M Naderi; S Sabour
Journal:  Cytopathology       Date:  2018-05-23       Impact factor: 2.073

6.  Inter-scan reproducibility of coronary calcium measurement using Multi Detector-Row Computed Tomography (MDCT).

Authors:  Siamak Sabour; A Rutten; Y T van der Schouw; F Atsma; D E Grobbee; W P Mali; M E L Bartelink; M L Bots; M Prokop
Journal:  Eur J Epidemiol       Date:  2007-04-11       Impact factor: 8.082

7.  The diagnostic value of D-dimer with simplified Geneva score (SGS) pre-test in the diagnosis of pulmonary embolism (PE).

Authors:  Zhihui Fu; Xibin Zhuang; Yueming He; Hong Huang; Weifeng Guo
Journal:  J Cardiothorac Surg       Date:  2020-07-20       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.